|
Volumn 21, Issue 2, 2003, Pages 273-274
|
A single infusion of infliximab increases the serum endostatin level in patients with rheumatoid arthritis [8]
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANGIOGENIC FACTOR;
ANTIRHEUMATIC AGENT;
C REACTIVE PROTEIN;
ENDOSTATIN;
INFLIXIMAB;
METHOTREXATE;
RHEUMATOID FACTOR;
ADULT;
ANGIOGENESIS;
BLOOD LEVEL;
BLOOD SAMPLING;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
DIET RESTRICTION;
DRUG EFFECT;
DRUG INFUSION;
ENZYME IMMUNOASSAY;
ERYTHROCYTE SEDIMENTATION RATE;
FEMALE;
HUMAN;
HUMAN TISSUE;
LETTER;
PANNUS;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
RHEUMATOID ARTHRITIS;
STATISTICAL ANALYSIS;
SYNOVIAL FLUID;
ADULT;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
COLLAGEN;
ENDOSTATINS;
FEMALE;
HUMANS;
INFUSIONS, PARENTERAL;
MIDDLE AGED;
NEOVASCULARIZATION, PATHOLOGIC;
PEPTIDE FRAGMENTS;
|
EID: 0037367706
PISSN: 0392856X
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (15)
|
References (7)
|